Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT03971253

Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis

Conditions: Rheumatoid Arthritis (RA)

Sex: All

Healthy volunteers: No

Enrollment: 3000

Sponsor: Astellas Pharma Inc

Location: Site JP00023 Aichi

Summary

The objective of this study is to investigate the safety and effectiveness in routine clinical practice and actual clinical setting for all patients with rheumatoid arthritis (RA) treated with peficitinib.

Eligibility Criteria

Inclusion Criteria: * All patients with rheumatoid arthritis (RA) treated with peficitinib for the first time. Exclusion Criteria: * Not applicable.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03971253). StuddyBuddy aggregates publicly available trial information.